|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions |
ISO |
Ethidium inhibits the reaction [Estradiol results in increased expression of BCL2 mRNA] |
CTD |
PMID:15897899 |
|
NCBI chr13:23,204,464...23,366,900
|
|
G |
Ccnd1 |
cyclin D1 |
multiple interactions |
ISO |
Ethidium inhibits the reaction [Estradiol results in increased expression of CCND1 mRNA] |
CTD |
PMID:15897899 |
|
NCBI chr 1:209,518,288...209,527,986
|
|
G |
Ccne1 |
cyclin E1 |
multiple interactions |
ISO |
Ethidium inhibits the reaction [Estradiol results in increased expression of CCNE1 mRNA] |
CTD |
PMID:15897899 |
|
NCBI chr 1:99,918,672...99,927,986
|
|
G |
Ccne2 |
cyclin E2 |
multiple interactions |
ISO |
Ethidium inhibits the reaction [Estradiol results in increased expression of CCNE2 mRNA] |
CTD |
PMID:15897899 |
|
NCBI chr 5:29,082,169...29,094,879
|
|
G |
Cd59b |
CD59b molecule |
increases mutagenesis |
ISO |
Ethidium results in increased mutagenesis of CD59 protein |
CTD |
PMID:17045307 |
|
NCBI chr 3:110,914,008...110,932,489
|
|
G |
Ero1a |
endoplasmic reticulum oxidoreductase 1 alpha |
multiple interactions |
ISO |
[Pyruvic Acid co-treated with Uridine co-treated with Ethidium] inhibits the reaction [Rotenone inhibits the reaction [arsenite results in increased expression of ERO1A protein]] |
CTD |
PMID:37659621 |
|
NCBI chr15:18,495,037...18,530,440
|
|
G |
Gja1 |
gap junction protein, alpha 1 |
increases uptake |
EXP |
GJA1 protein results in increased uptake of Ethidium |
CTD |
PMID:26926986 |
|
NCBI chr20:36,302,490...36,315,010
|
|
G |
Il1a |
interleukin 1 alpha |
multiple interactions |
ISO |
Ethidium inhibits the reaction [sodium arsenate results in increased expression of IL1A protein]; Ethidium inhibits the reaction [tributyltin results in increased expression of IL1A protein] |
CTD |
PMID:8875956 PMID:10571731 |
|
NCBI chr 3:136,979,804...136,990,236
|
|
G |
Mt-co1 |
mitochondrially encoded cytochrome c oxidase I |
decreases expression |
ISO |
Ethidium results in decreased expression of COX1 protein |
CTD |
PMID:18823003 |
|
|
|
G |
Mt-co2 |
mitochondrially encoded cytochrome c oxidase II |
decreases expression |
ISO |
Ethidium results in decreased expression of COX2 mRNA |
CTD |
PMID:22712077 |
|
|
|
G |
Mt-cyb |
mitochondrially encoded cytochrome b |
decreases expression |
ISO |
Ethidium results in decreased expression of CYTB mRNA |
CTD |
PMID:22712077 |
|
NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278 NCBI chr MT:14,136...15,278
|
|
G |
Mt-nd1 |
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1 |
decreases expression |
ISO |
Ethidium results in decreased expression of ND1 mRNA |
CTD |
PMID:22712077 |
|
NCBI chr MT:2,740...3,694 NCBI chr MT:2,740...3,694 NCBI chr MT:2,740...3,694
|
|
G |
Mt-nd4 |
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4 |
decreases expression |
ISO |
Ethidium results in decreased expression of ND4 mRNA |
CTD |
PMID:22712077 |
|
NCBI chr MT:10,160...11,537 NCBI chr MT:10,160...11,537 NCBI chr MT:10,160...11,537 NCBI chr MT:10,160...11,537 NCBI chr MT:10,160...11,537 NCBI chr MT:10,160...11,537 NCBI chr MT:10,160...11,537 NCBI chr MT:10,160...11,537 NCBI chr MT:10,160...11,537 NCBI chr MT:10,160...11,537 NCBI chr MT:10,160...11,537 NCBI chr MT:10,160...11,537 NCBI chr MT:10,160...11,537
|
|
G |
Nrf1 |
nuclear respiratory factor 1 |
increases expression |
ISO |
Ethidium results in increased expression of NRF1 mRNA |
CTD |
PMID:22712077 |
|
NCBI chr 4:58,664,932...58,772,328
|
|
G |
P2rx7 |
purinergic receptor P2X 7 |
decreases transport increases transport |
ISO |
P2RX7 gene polymorphism results in decreased transport of Ethidium P2RX7 protein results in increased transport of Ethidium |
CTD |
PMID:16263709 |
|
NCBI chr12:39,550,531...39,594,984
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
Ethidium inhibits the reaction [cyanoginosin LR results in increased phosphorylation of RELA protein] |
CTD |
PMID:35032610 |
|
NCBI chr 1:212,354,336...212,364,815
|
|
G |
Slc22a1 |
solute carrier family 22 member 1 |
multiple interactions affects uptake increases uptake |
ISO |
1-Methyl-4-phenylpyridinium inhibits the reaction [SLC22A1 protein results in increased uptake of Ethidium]; Cimetidine inhibits the reaction [SLC22A1 protein results in increased uptake of Ethidium]; Quinine inhibits the reaction [SLC22A1 protein results in increased uptake of Ethidium]; Tetraethylammonium inhibits the reaction [SLC22A1 protein results in increased uptake of Ethidium] SLC22A1 protein affects the uptake of Ethidium |
CTD |
PMID:19357179 |
|
NCBI chr 1:50,624,339...50,651,437
|
|
G |
Slc22a2 |
solute carrier family 22 member 2 |
affects uptake increases uptake multiple interactions |
ISO |
SLC22A2 protein affects the uptake of Ethidium SLC22A2 protein results in increased uptake of Ethidium 1-Methyl-4-phenylpyridinium inhibits the reaction [SLC22A2 protein results in increased uptake of Ethidium]; Cimetidine inhibits the reaction [SLC22A2 protein results in increased uptake of Ethidium]; Ethidium inhibits the reaction [SLC22A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium]; Quinine inhibits the reaction [SLC22A2 protein results in increased uptake of Ethidium]; Tetraethylammonium inhibits the reaction [SLC22A2 protein results in increased uptake of Ethidium] |
CTD |
PMID:19357179 |
|
NCBI chr 1:50,668,817...50,711,019
|
|
G |
Slc22a3 |
solute carrier family 22 member 3 |
increases uptake multiple interactions |
ISO |
SLC22A3 protein results in increased uptake of Ethidium 1-Methyl-4-phenylpyridinium inhibits the reaction [SLC22A3 protein results in increased uptake of Ethidium]; Cimetidine inhibits the reaction [SLC22A3 protein results in increased uptake of Ethidium]; Quinine inhibits the reaction [SLC22A3 protein results in increased uptake of Ethidium]; Tetraethylammonium inhibits the reaction [SLC22A3 protein results in increased uptake of Ethidium] |
CTD |
PMID:19357179 |
|
NCBI chr 1:50,783,218...50,872,358
|
|
G |
Sting1 |
stimulator of interferon response cGAMP interactor 1 |
multiple interactions |
ISO |
Ethidium inhibits the reaction [cyanoginosin LR results in increased expression of STING1 protein] |
CTD |
PMID:35032610 |
|
NCBI chr18:27,606,196...27,612,544
|
|
G |
Tfam |
transcription factor A, mitochondrial |
increases expression |
ISO |
Ethidium results in increased expression of TFAM mRNA |
CTD |
PMID:22712077 |
|
NCBI chr20:17,356,243...17,368,293
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
Ethidium inhibits the reaction [cyanoginosin LR results in increased expression of TNF mRNA] |
CTD |
PMID:35032610 |
|
NCBI chr20:3,626,685...3,629,303
|
|
G |
Tp53 |
tumor protein p53 |
affects activity |
ISO |
Ethidium affects the activity of TP53 protein |
CTD |
PMID:35435491 |
|
NCBI chr10:54,798,871...54,810,300
|
|